EUVIMED · CrossrefZeitschrift
Current Controlled Trials in Cardiovascular Medicine
ISSN 1468-6694 · Springer Science and Business Media LLC
Neueste Artikel
The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial
Weight-modification trials in older adults: what should the outcome measure be?
Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone
Clinical significance of cardiovascular dysmetabolic syndrome
The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice
Problems in dealing with missing data and informative censoring in clinical trials
Long-term vitamin E supplementation fails to reduce lipid peroxidation in people at cardiovascular risk: analysis of underlying factors
Pooling, meta-analysis, and the evaluation of drug safety
A Review of the Adverse Effects of Peripheral Alpha-1 Antagonists in Hypertension Therapy
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics
A randomized controlled trial of an extensive lifestyle management intervention (ELMI) following cardiac rehabilitation: study design and baseline data
Effects of a comprehensive cardiac rehabilitation program on quality of life and exercise tolerance in women: A retrospective analysis
Effect of Omacor on HRV parameters in patients with recent uncomplicated myocardial infarction – A randomized, parallel group, double-blind, placebo-controlled trial: study design [ISRCTN75358739]
Effects of oral anticoagulation with various INR levels in deep vein thrombosis cases
Elevated levels of matrix metalloprotein-3 in patients with coronary aneurysm: A case control study
Early and long-term outcome of elective stenting of the infarct-related artery in patients with viability in the infarct-area: Rationale and design of the Viability-guided Angioplasty after acute Myocardial Infarction-trial (The VIAMI-trial)
A trial design for evaluation of empiric programming of implantable cardioverter defibrillators to improve patient management
Unanswered ethical and scientific questions for trials of invasive interventions for coronary disease: The case of single vessel disease
Anticoagulation for non-valvular atrial aibrillation – towards a new beginning with ximelagatran
Current trends in the cardiovascular clinical trial arena (I)
Informative noncompliance in endpoint trials
Balancing commercial and public interests
Individualizing therapy – in search of approaches to maximize the benefit of drug treatment (II)
Equivalence and noninferiority trials – are they viable alternatives for registration of new drugs? (III)
A novel approach to treatment of hypertension in diabetic patients – a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 – rationale and design [ISRCTN55725285]
Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities
Exercise training improves aerobic endurance and musculoskeletal fitness in female cardiac transplant recipients
The SPHERE Study. Secondary prevention of heart disease in general practice: protocol of a randomised controlled trial of tailored practice and patient care plans with parallel qualitative, economic and policy analyses. [ISRCTN24081411]
Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction
Coronary artery bypass surgery in high-risk patients
EUVIMED